Interleukin-4 receptor: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 1: | Line 1: | ||
{{DISPLAYTITLE:Interleukin-4 receptor}} | |||
[[File:PDB_1iar_EBI.jpg|thumb|right|Structure of the Interleukin-4 receptor]] | |||
The IL-4R is a type I [[ | The '''interleukin-4 receptor''' (IL-4R) is a type I cytokine receptor that binds [[interleukin-4]] (IL-4) and [[interleukin-13]] (IL-13). It plays a crucial role in the [[immune system]] by mediating the effects of these cytokines, which are involved in the regulation of [[immune response]]s, particularly in [[allergy|allergic]] reactions and [[asthma]]. | ||
== | ==Structure== | ||
The IL-4 receptor is a complex composed of multiple subunits. The primary subunit is the IL-4R_ chain, which is shared with the IL-13 receptor. The receptor can form two types of complexes: the type I receptor, which consists of IL-4R_ and the common gamma chain (_c), and the type II receptor, which consists of IL-4R_ and the IL-13R_1 chain. | |||
The | ==Function== | ||
The IL-4 receptor is involved in the signaling pathways that lead to the differentiation of [[T helper cell|T helper 2 (Th2) cells]], which are essential for the production of [[immunoglobulin E]] (IgE) and the promotion of [[B cell]] class switching. This receptor is also implicated in the regulation of [[macrophage]] activation and the modulation of [[inflammation]]. | |||
== | ==Signaling Pathway== | ||
Upon binding of IL-4 or IL-13, the IL-4 receptor undergoes a conformational change that activates the associated [[Janus kinase]]s (JAKs). This activation leads to the phosphorylation of the receptor and the recruitment of [[signal transducer and activator of transcription]] (STAT) proteins, particularly STAT6. Phosphorylated STAT6 dimerizes and translocates to the [[cell nucleus]], where it acts as a transcription factor to regulate the expression of target genes involved in immune responses. | |||
==Clinical Significance== | |||
Dysregulation of IL-4 receptor signaling is associated with various [[allergic disease]]s, including [[asthma]], [[atopic dermatitis]], and [[allergic rhinitis]]. Therapeutic targeting of the IL-4 receptor, such as with monoclonal antibodies, is a strategy used in the treatment of these conditions. For example, [[dupilumab]] is a monoclonal antibody that inhibits IL-4 and IL-13 signaling by blocking the IL-4R_ subunit. | |||
== | ==Research== | ||
Ongoing research is focused on understanding the detailed mechanisms of IL-4 receptor signaling and its role in immune regulation. Studies are also exploring the potential of IL-4 receptor antagonists in the treatment of other inflammatory and autoimmune diseases. | |||
==Related pages== | |||
* [[Interleukin-4]] | * [[Interleukin-4]] | ||
* [[Interleukin-13]] | * [[Interleukin-13]] | ||
* [[Cytokine receptor]] | * [[Cytokine receptor]] | ||
* [[ | * [[Janus kinase]] | ||
* [[Signal transducer and activator of transcription]] | |||
[[Category:Immunology]] | |||
[[Category: | |||
[[Category:Receptors]] | [[Category:Receptors]] | ||
Latest revision as of 11:13, 15 February 2025
The interleukin-4 receptor (IL-4R) is a type I cytokine receptor that binds interleukin-4 (IL-4) and interleukin-13 (IL-13). It plays a crucial role in the immune system by mediating the effects of these cytokines, which are involved in the regulation of immune responses, particularly in allergic reactions and asthma.
Structure[edit]
The IL-4 receptor is a complex composed of multiple subunits. The primary subunit is the IL-4R_ chain, which is shared with the IL-13 receptor. The receptor can form two types of complexes: the type I receptor, which consists of IL-4R_ and the common gamma chain (_c), and the type II receptor, which consists of IL-4R_ and the IL-13R_1 chain.
Function[edit]
The IL-4 receptor is involved in the signaling pathways that lead to the differentiation of T helper 2 (Th2) cells, which are essential for the production of immunoglobulin E (IgE) and the promotion of B cell class switching. This receptor is also implicated in the regulation of macrophage activation and the modulation of inflammation.
Signaling Pathway[edit]
Upon binding of IL-4 or IL-13, the IL-4 receptor undergoes a conformational change that activates the associated Janus kinases (JAKs). This activation leads to the phosphorylation of the receptor and the recruitment of signal transducer and activator of transcription (STAT) proteins, particularly STAT6. Phosphorylated STAT6 dimerizes and translocates to the cell nucleus, where it acts as a transcription factor to regulate the expression of target genes involved in immune responses.
Clinical Significance[edit]
Dysregulation of IL-4 receptor signaling is associated with various allergic diseases, including asthma, atopic dermatitis, and allergic rhinitis. Therapeutic targeting of the IL-4 receptor, such as with monoclonal antibodies, is a strategy used in the treatment of these conditions. For example, dupilumab is a monoclonal antibody that inhibits IL-4 and IL-13 signaling by blocking the IL-4R_ subunit.
Research[edit]
Ongoing research is focused on understanding the detailed mechanisms of IL-4 receptor signaling and its role in immune regulation. Studies are also exploring the potential of IL-4 receptor antagonists in the treatment of other inflammatory and autoimmune diseases.
